While some predictive biomarkers have been identified, such as tumor programmed cell death ligand-1 (PD-L1) expression and tumor mutational burden, their performance may not be optimal and bring some practical issues including technical challenges and imperfect efficiency in accurately predicting ICIs responses4. Here, CD274 is linked to neoplasm.